Project Details
Short title | Second Arm - Two Arm, Randomised (2:1), Open- label Phase 11/111 Study in EpCAM Positive Cancer Patients with Symptomatic Malignant Ascites Using Paracentesis Plus the Tri-Functional Antibody Removab (Anti-EpCAM x Anti-CD3 versus Paracent. |
---|---|
Status | Finished |
Effective start/end date | 1/10/04 → 31/12/06 |
Funding
- Queen Elizabeth Hospital